Companies · Other Health Care
BOSTON · Other Health Care
Diligence memoA one-page analyst read on ENT&C Holdings LLC — recommendation, valuation, rhythm, risks.→ENT&C Holdings LLC looks over-valued against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
ENT&C Holdings LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
ENT&C Holdings LLC is one of 5376 Other Health Care companies tracked from BOSTON. By capital raised it ranks in the upper tier (ahead of 88% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.
Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 88% of sector peers (real $). Modeled value above 95% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #17 of 74.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Podicare Services, Inc. | Series B | $40.0M | $886.2M | 1.98× |
| COTA, Inc. | Series B | $43.8M | $886.2M | 1.98× |
| Fresenius Medical Care - Meridian Health System, LLC | Series B | $39.0M | $863.9M | 1.93× |
| Headspace, Inc. | Series B | $115.9M | $860.6M | 1.92× |
| Spine Holdings LLC | Series B | $38.4M | $851.6M | 1.90× |
| Chrono Therapeutics Inc. | Series B | $51.4M | $833.2M | 1.86× |
| MedCPU, Inc. | Series B | $36.6M | $776.2M | 1.73× |
| Capital Funding Bancorp, Inc. | Series B | $35.0M | $775.4M | 1.73× |
| Phreesia, Inc. | Series B | $83.8M | $753.2M | 1.68× |
| Labconnect Holdings, Inc. | Series B | $33.4M | $739.0M | 1.65× |
| Zoonie, LLC | Series B | $52.0M | $708.1M | 1.58× |
| Sotera Wireless, Inc. | Series B | $98.5M | $705.3M | 1.58× |
| ENT&C Holdings LLC this company | Series B | $30.7M | $681.1M | 1.52× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series B | $30.7M | 2018-09-13 | $170.8M | $681.1M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Stephen M. Jenks | — | 5 other | 2018-09 |
| Alexander S. McGrath | — | 4 other | 2018-09 |
| Benjamin M. Geis | — | 1 other | 2018-09 |
| D. Andrew Tatman II | — | 1 other | 2018-09 |
| John L. Davis | — | 1 other | 2018-09 |
ENT&C Holdings LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Claris Vision Holdings LLC | Other Health Care | Series B | $44.4M | $11.1M | network3 shared operators · same sector · same stage |
| Spine Holdings LLC | Other Health Care | Series B | $38.4M | $851.6M | network2 shared operators · same sector · same stage |
| Candescent Healing LLC | Other Health Care | Series B | $21.5M | $476.6M | network1 shared operator · same sector · same stage |
| Oliver Street Dermatology Holdings LLC | Other Health Care | Series C | $109.7M | $13.1M | network2 shared operators · same sector |
| Motion PT Holdings, Inc. | Other Health Care | Series B | $30.7M | $680.9M | same sector · same stage |
| Arivale Inc. | Other Health Care | Series B | $30.6M | $301.3M | same sector · same stage |
| Drfirst Com Inc | Other Health Care | Series B | $31.0M | $553.9M | same sector · same stage |
| Fresenius Vascular Care San Antonio MSO, LLC | Other Health Care | Series B | $30.3M | $672.2M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| EndoscopyMD Holdings, LLC | Other Health Care | Series B | $157.0M | 86% |
| ENTPSA ASC HoldCo, LLC | Other Health Care | Pre-Seed | $3.9M | 85% |
| Coastal Administrative Holdings LLC | Other Health Care | Pre-Seed | $824K | 85% |
| PDC Holdings, LLC | Other Health Care | Seed | $32.6M | 84% |
| CHWY RE Holdings, LLC | Other Health Care | Pre-Seed | $17.1M | 84% |
| InvestCo Ennis, TX, LLC | Other Health Care | Seed | $47.3M | 84% |
| Ensage, Inc. | Other Health Care | Seed | $15.3M | 84% |
| C21 Investments Inc. | Other Health Care | Series A | $161.6M | 84% |
See where ENT&C Holdings LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at ENT&C Holdings LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.